skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 13
Patent #:
NONE
Issue Dt:
Application #:
10588254
Filing Dt:
08/14/2008
Publication #:
20080306029
Pub Dt:
12/11/2008
PCT #:
US0518757
Inventors:
Doug Bettenhausen, Christopher Jahraus
Title:
Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
Assignment: 1
Reel/Frame:
017455/0642Recorded: 04/11/2006Pages: 7
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
JAHRAUS, MD, DR CHRISTOPHER DEAN
Exec Dt:
07/01/2005
Assignee:
ASSURANCE ONCOLOGY SERVICES, LLC
70 BOWDEN CIRCLE
CHELSEA, ALABAMA 35043
Correspondent:
CHRISTOPHER D JAHRAUS
70 BOWDEN CIRCLE
CHELSEA, AL 35043
Assignment: 2
Reel/Frame:
017209/0618Recorded: 01/24/2006Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
BETTENHAUSEN, DOUG
Exec Dt:
12/20/2005
Assignee:
SALIX PHARMACEUTICALS, INC.
1700 PERIMETER PARK DRIVE
MORRISVILLE, NORTH CAROLINA 27560
Correspondent:
LINDA M. BUCKLEY
EDWARDS ANGELL PALMER & DODGE LLP
P.O. BOX 55874
BOSTON, MA 02205
Assignment: 3
Reel/Frame:
017999/0822Recorded: 07/24/2006Pages: 7
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
ASSURANCE ONCOLOGY SERVICES, LLC
Exec Dt:
06/28/2006
Assignee:
SALIX PHARMACEUTICALS, INC.
1700 PERIMETER PARK DRIVE
MORRISVILLE, NORTH CAROLINA 27560
Correspondent:
LINDA M. BUCKLEY
EDWARDS ANGELL PALMER & DODGE LLP
P.O. BOX 55874
BOSTON, MA 02205
Assignment: 4
Reel/Frame:
019201/0029Recorded: 04/23/2007Pages: 7
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
BETTENHAUSEN, DOUG
Exec Dt:
02/20/2007
Assignee:
SALIX PHARMACEUTICALS, INC.
1700 PERIMETER PARK DRIVE
MORRISVILLE, NORTH CAROLINA 27560
Correspondent:
LINDA M. BUCKLEY
EDWARDS ANGELL PALMER, ET AL.
P.O. BOX 55874
BOSTON, MA 02205
Assignment: 5
Reel/Frame:
018951/0348Recorded: 03/02/2007Pages: 11
Conveyance:
SECURITY AGREEMENT
Assignor:
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/22/2007
Assignee:
BANK OF AMERICA, N.A.
101 NORTH TRYON STREET
MAIL CODE: NC1-001-04-39
CHARLOTTE, NORTH CAROLINA 28255
Correspondent:
KARL S. SAWYER, JR.
214 N TRYON ST., HEARST TOWER 47TH FLOOR
KENNEDY COVINGTON LOBDELL & HICKMAN, LLP
CHARLOTTE, NC 28202
Assignment: 6
Reel/Frame:
018951/0348Recorded: 03/02/2007Pages: 11
Conveyance:
SECURITY AGREEMENT
Assignor:
SALIX PHARMACEUTICALS, INC.
Exec Dt:
02/22/2007
Assignee:
BANK OF AMERICA, N.A.
101 NORTH TRYON STREET
MAIL CODE: NC1-001-04-39
CHARLOTTE, NORTH CAROLINA 28255
Correspondent:
KARL S. SAWYER, JR.
214 N TRYON ST., HEARST TOWER 47TH FLOOR
KENNEDY COVINGTON LOBDELL & HICKMAN, LLP
CHARLOTTE, NC 28202
Assignment: 7
Reel/Frame:
024463/0463Recorded: 06/01/2010Pages: 9
Conveyance:
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Assignor:
BANK OF AMERICA, N.A.
Exec Dt:
05/19/2010
Assignee:
SALIX PHARMACEUTICALS, INC.
1700 PERIMETER PARK DRIVE
MORRISVILLE, NORTH CAROLINA 27560
Correspondent:
CHRISTOPHER L. SOREY, ESQ.
4101 LAKE BOONE TRAIL
SUITE 300
RALEIGH, NC 27607
Assignment: 8
Reel/Frame:
031901/0283Recorded: 01/02/2014Pages: 7
Conveyance:
SECURITY AGREEMENT
Assignor:
SALIX PHARMACEUTICALS, INC.
Exec Dt:
01/02/2014
Assignee:
JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
520 MADISON AVENUE
NEW YORK, NEW YORK 10022
Correspondent:
COVINGTON & BURLING LLP
1201 PENNSYLVANIA AVENUE NW
ATTN: PATENT DOCKETING
WASHINGTON, DC 20004
Assignment: 9
Reel/Frame:
031901/0283Recorded: 01/02/2014Pages: 7
Conveyance:
SECURITY AGREEMENT
Assignor:
SALIX PHARMACEUTICALS, INC.
Exec Dt:
01/02/2014
Assignee:
JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
520 MADISON AVENUE
NEW YORK, NEW YORK 10022
Correspondent:
COVINGTON & BURLING LLP
1201 PENNSYLVANIA AVENUE NW
ATTN: PATENT DOCKETING
WASHINGTON, DC 20004
Assignment: 10
Reel/Frame:
035356/0519Recorded: 04/01/2015Pages: 6
Conveyance:
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Assignor:
JEFFERIES FINANCE LLC
Exec Dt:
04/01/2015
Assignee:
SALIX PHARMACEUTICALS, INC.
8510 COLONNADE CENTER DRIVE
RALEIGH, NORTH CAROLINA 27615
Correspondent:
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
FOUR TIMES SQUARE
JUSTIN SELLE, LEGAL ASSISTANT
NEW YORK, NY 10036
Assignment: 11
Reel/Frame:
035356/0519Recorded: 04/01/2015Pages: 6
Conveyance:
RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).
Assignor:
JEFFERIES FINANCE LLC
Exec Dt:
04/01/2015
Assignee:
SALIX PHARMACEUTICALS, INC.
8510 COLONNADE CENTER DRIVE
RALEIGH, NORTH CAROLINA 27615
Correspondent:
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
FOUR TIMES SQUARE
JUSTIN SELLE, LEGAL ASSISTANT
NEW YORK, NY 10036
Assignment: 12
Reel/Frame:
035364/0396Recorded: 04/02/2015Pages: 81
Conveyance:
SECURITY AGREEMENT
Assignors:
GLYCYX PHARMACEUTICALS, LTD.
Exec Dt:
04/01/2015
SALIX PHARMACEUTICALS, INC.
Exec Dt:
04/01/2015
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
04/01/2015
SANTARUS, INC.
Exec Dt:
04/01/2015
Assignee:
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE
NEW YORK, NEW YORK 10019
Correspondent:
ELAINE CARRERA, LEGAL ASSISTANT
80 PINE STREET
C/O CAHILL GORDON & REINDEL LLP
NEW YORK, NY 10005
Assignment: 13
Reel/Frame:
035364/0396Recorded: 04/02/2015Pages: 81
Conveyance:
SECURITY AGREEMENT
Assignors:
GLYCYX PHARMACEUTICALS, LTD.
Exec Dt:
04/01/2015
SALIX PHARMACEUTICALS, INC.
Exec Dt:
04/01/2015
SALIX PHARMACEUTICALS, LTD.
Exec Dt:
04/01/2015
SANTARUS, INC.
Exec Dt:
04/01/2015
Assignee:
BARCLAYS BANK PLC, AS COLLATERAL AGENT
745 SEVENTH AVENUE
NEW YORK, NEW YORK 10019
Correspondent:
ELAINE CARRERA, LEGAL ASSISTANT
80 PINE STREET
C/O CAHILL GORDON & REINDEL LLP
NEW YORK, NY 10005

Search Results as of: 05/08/2024 10:31 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT